Capital One Investing’s Allergan plc AGN Stock Holding History

Capital One Investing’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,510	Closed	-$221K	–	196
2019 Q1	$221K	Buy	+1,510	New	+$219K	0.06%	174

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital One Investing's AGN Position: Q2 2019 in Review

Capital One Investing sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,510 shares — an estimated $221K sold.

Capital One Investing first reported a position in AGN in Q1 2019 and held it in 1 quarter. The position peaked at $221K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Capital One Investing reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Capital One Investing sold 1,510 Allergan plc shares in Q2 2019, an estimated $221K.
Capital One Investing first reported a position in Allergan plc in Q1 2019 and held it in 1 quarter.
Capital One Investing's Allergan plc position peaked at $221K in Q1 2019.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Capital One Investing's 13F filing for Q2 2019, filed 6 Aug 2019.